Keywords
How to Cite
Abstract
SUBCLINICAL CARDIAC DAMAGE IN CARDIOPULMONARY POLYMORBIDITY. (review). Part 1.
Ashcheulova T., Ambrosova T., Kochubiei O., Honchar O., Sytina I.
Hypertension and chronic obstructive pulmonary disease are one of the frequent comorbid conditions in internal medicine and are subject to meaningful cooperation among physicians, cardiologists, and pulmonologists.
A combination of chronic obstructive pulmonary disease and hypertension presents certain diagnostic and therapeutic challenges. These conditions share common risk factors, similar clinical presentations and some common parts of pathogenesis. The problem of association between chronic obstructive pulmonary disease and hypertension may be currently discusses both as a simple combination of various clinical entities, and as chronic obstructive pulmonary disease resulting in development of factors contributing to hypertension. One way or another, either a simple combination, or a mutually aggravating syndrome, but we state there is a cardiorespiratory continuum where chronic obstructive pulmonary disease acts as a valid component of hypertension development, and vice versa. Thus, it seems to be relevant to study peculiarities of the structural and functional status of the cardiovascular system and microcirculation, systemic remodeling mechanisms, endothelial dysfunction and inflammation in presence of chronic obstructive pulmonary disease -associated hypertension. Problems of additional cardiovascular risk marker development, treatment efficiency assessment remain topical.
Use of electrocardiography and echocardiography with dopplerometry has been an important diagnostic principle of subclinical cardiovascular damage in presence of hypertension and chronic obstructive pulmonary disease comorbidity. Non-invasive imaging methods play a central part in diagnostics of subclinical target organ damage. Wide implementation thereof is based on high diagnostic accuracy, common availability, safety and relatively low price.
Key words: hypertension, chronic obstructive pulmonary disease, comorbidity, electrocardiography, echocardiography with dopplerometry
Резюме.
СУБКЛІНІЧНЕ УРАЖЕННЯ СЕРЦЯ ПРИ КАРДІОПУЛЬМОНАЛЬНІЙ ПОЛІМОРБІДНОСТІ (огляд). Частина 1.
Ащеулова Т.В., Амбросова Т.М., Кочубєй О.А., Гончарь О.В., Ситіна І.В.
Артеріальна гіпертензія і хронічне обструктивне захворювання легень - одне з частих коморбідних станів в клініці внутрішніх хвороб і є предметом конструктивної взаємодії терапевтів, кардіологів, пульмонологів.
Поєднання хронічного обструктивного захворювання легень і артеріальної гіпертензії являє певні труднощі для діагностики і лікування. Ці захворювання мають загальні фактори ризику, схожі клінічні прояви і спільність деяких ланок патогенезу. Таким чином, представляється актуальним дослідження особливостей структурно-функціонального стану серцево-судинної системи і мікроциркуляції, вивчення системних механізмів ремоделювання, ендотеліальної дисфункції та запалення при артеріальній гіпертензії в поєднанні з хронічним обструктивним захворюванням легень. Залишаються актуальними питання розробки додаткових маркерів серцево-судинного ризику, оцінки ефективності проведеного лікування.
В останні роки важливими принципами діагностики субклінічного ураження серця і судин при коморбідності хронічного обструктивного захворювання легень і артеріальної гіпертензії є використання електрокардіографії та ехокардіографії з доплерометрією. Неінвазивні методи візуалізації відіграють центральну роль в діагностиці субклінічного ураження органів-мішеней. Їх широке застосування обумовлено високою діагностичної точністю, повсюдною поширеністю, безпекою і відносно низькою вартістю.
Ключові слова. Артеріальна гіпертензія, хронічне обструктивне захворювання легень, коморбідность, електрокардіографія, ехокардіографія з доплерометрією.
Резюме.
СУБКЛИНИЧЕСКОЕ ПОРАЖЕНИЕ СЕРДЦА ПРИ КАРДИОПУЛЬМОНАЛЬНОЙ ПОЛИМОРБИДНОСТИ (обзор). Часть 1.
Ащеулова Т.В., Амбросова Т.Н., Кочубей О.А., Гончарь А.В., Сытина И.В.
Артериальная гипертензия и хроническое обструктивное заболевание легких - одно из частых коморбидных состояний в клинике внутренних болезней и являются предметом конструктивного взаимодействия терапевтов, кардиологов, пульмонологов.
Сочетание хронического обструктивного заболевания легких и артериальной гипертензии представляет определенные трудности для диагностики и лечения. Эти заболевания имеют общие факторы риска, схожие клинические проявления и общность некоторых звеньев патогенеза. Таким образом, представляется актуальным исследование особенностей структурно-функционального состояния сердечно-сосудистой системы и микроциркуляции, изучение системных механизмов ремоделирования, эндотелиальной дисфункции и воспаления при артериальной гипертензии в сочетании с хроническим обструктивным заболеванием легких. Остаются актуальными вопросы разработки дополнительных маркеров сердечно-сосудистого риска, оценки эффективности проводимого лечения.
В последние годы важными принципами диагностики субклинического поражения сердца и сосудов при коморбидности хронического обструктивного заболевания легких и артериальной гипертензии является использование электрокардиографии и эхокардиографии с допплерометрией. Неинвазивные методы визуализации играют центральную роль в диагностике субклинического поражения органов-мишеней. Их широкое применение обусловлено высокой диагностической точностью, повсеместной распространенностью, безопасностью и относительно низкой стоимостью.
Ключевые слова. Артериальная гипертензия, хроническое обструктивное заболевание легких, коморбидность, электрокардиография, эхокардиография с допплерометрией.
References
1. Global Initiative for Chronic Obstructive Lung Disease. Executive summary: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Reprint. 2003. Retrieved from
http://www.scamfyc.org/documentos/GOLDes2004modified.pdf
Barnes, P.J., Celli, B.R. (2009). Systemic manifestations and comorbidities of COPD. European Respiratory Journal, 33(5),1165–1185.
Fabbri, L.M., Luppi, F., Beghe, B., Rabe, K.F. (2008). Complex chronic comorbidities of COPD. European Respiratory Journal. 31(1), 204–212.
Agustf, A., Nogucra, A., Saaleda, J. (2003). Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal, 21, 347–360.
Andreessen, H., Vestbo, J. (2003). Chronic obstructive pulmonary disease as a systemic disease: an epidemiclogical perspective. European Respiratory Journal, 22 ( 46): 2–4.
Gumenyuk, M.I., Ignatieva, V I., Matvienko, Yu. O. (2014). Systemic inflammation markers in patients with chronic obstructive pulmonary disease. Ukrainian Pulmonologist Journal, 3, 33–36.
Magnussen, H., Watz, H. (2009). Systemic inflammation in COPD and asthma: relation with comorbidities. Proceedings of the American Thoracic Society, 8 (6), 648–651.
Chatila, W. M., Thomashow, B. M., Minai, O. A. (2008). Comorbidities in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 4 (5), 549–555.
Van, Eden, S. F., Sin D. D.. (2008). Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration, 2 (75), 224–238.
Murali, Mohan B.V., Sen, T., Ranganatha, R. (2012). Systemic Manifestations of COPD Journal of the Association of Physicians of India., 60, 44-47.
Fabbri, L. M., Luppi, F., Beghe, B., Rabe, K. F. (2008). Complex chronic comorbidities of COPD. European Respiratory Journal. 1 (31), 204–212.
Barnes, P. J., Celli, B.R. (2009). Systemic manifestations and comorbidities of COPD. European Respiratory Journal, 5 (33), 1165–1185.
Magnussen, H., Watz H. (2009). Systemic inflammation in COPD and asthma: relation with comorbidities. Proceedings of the American Thoracic Society, 8 (6), 648–651.
Barbera, J.A., Peinado, V., Santos, S. (2003). Pulmonary hypertension in chronic obstructive pulmonary disease. European Respiratory Jour, 21, 892–905.
Weitzenblum E. (2003). Chronic cor pulmonale. Heart, 89 (2), 225–30.
Barnes, P.J. (2000). Chronic obstructive pulmonary disease. N. Engl. J. Med, 343, 269–80.
Schunemann, H. J. et al. (2000). Pulmonary function is a long-term predictor of mortality in the
general population: 29-year follow-up of the. Buffalo Health Study Chest, 118, 656–664.
Kaptoge, S. (2010). Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 375,
–140.
Zacho, J. (2008). Genetically elevated C-reactive protein and ischemic vascular disease. N. Engl.
J. Med, 359, 1897–1908.
Sabit, R. (2007) Arterial stiffness and osteoporosis in chronic obstructivepulmonary disease. Am.
J. Respir. Crit. Care Med, 175, 1259–1265.
Francios, L. G. (2006). Markers of disease severity in chronic obstructive pulmonary disease
Pulm. Pharmacol. Ther, 19, 189–199.
Brajer, B. (2008). Concentration of matrix metalloproteinase-9 in serum of patients with chronic
obstructive pulmonary disease and a degree of airway obstruction and disease progression. J. Physiol. Pharmacol, 6 ( 59), 145–152.
Cazzola, M. (2008). Outcomes for COPD pharmacological trials: from lung function to biomarkers. European Respiratory Jour, 31, 416–469.
Manisto, J., Haahtela, T. (1997). Leukotreiene receptor blockers and leukotriene synthesis inhibitors. Nord. Med, 4 (12), 122–125.
Majo, J. (2001). Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysem. European Respiratory Jour, 17, 46–953.
Lind, L. (2003). Circulating markers of inflammation and atherosclerosis. Atherosclerosis, 169, 203–214.
Freixa, X., Portillo, K., Pare, C., Garcia-Aymerich, J., Gomez, F. P. (2013). Echocardiographic abnormalities in patients with COPD at their first hospital admission.European Respiratory Jour, 2, 784–791. 28. Orlov, V.N. (2017). Manual for electrocardiography. 9-edition. Moscow: Medical Information
Agency Ltd, 560.
Allison, J.D., Macedo, F.Y., Hamzeh,I.R., Birnbaum, Y. (2017). Correlation of right atrial enlargement
on ECG to right atrial volume by echocardiography in patients with pulmonary hypertension. J Electrocardiol. 50(5), 555–560.
Tsao, C.W., Josephson, M.E., Hauser, T.H. et al. (2008). Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 10(1), 7.
Hancock, W E., Deal, B.J., Mirvis ,D.M., Okin,P., Kligfield,P., Gettes, L.S. (2009) AHA/ACCF/ HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. Circulation, 119:251–261.
Henkens, I.R., Mouchaers, K.T., Vonk-Noordegraaf, A., Boonstra, A., Swenne, C.A., Maan, A.C.,... Vliegen HW. (2008). Improved ECG detection of presence and severity of right ventricular pressure load validated with cardiac magnetic resonance imaging Quantitative Estimation of Right Ventricular Hypertrophy using ECG Criteria in Patients with Pulmonary Hypertension: A Comparison with Cardiac MRI Am J Physiol Heart Circ Physiol. 2150–2157.
Charipar, E.M., Ptaszek, L.M., Taylor, C., Fontes, J.D., Kriegel, M., Irlbeck, T., (2011). Usefulness of electrocardiographic parameters as compared with computed tomography measures of left atrial volume enlargement: from the ROMICAT trial. Truong QA1. J Electrocardiol. ;44(2), 257–64.
Bureekam, S., Boonyasirinant, T. (2014). Accuracy of left atrial enlargement diagnosed by electrocardiography as compared to cardiac magnetic resonance in hypertensive patients. J Med Assoc Thai, 3, 132–138.
Andlauer, R., Platonov, P. G., Olaf, Dossel. (2016). Gunnar Seemann Left atrial hypertrophy increases P-wave terminal force through amplitude but not duration Axel Loewe ; Computing in Cardiology Conference (CinC) Vancouver, BC, Canada, 1–4.
Zharinov, O.H., Ivaniv, Yu. A., Kuts, V.O. (2018). Functional diagnostics Kyiv: Fourth wave, 736.
Estes, E.H., Zhang, Z.M., Li, Y., Tereschenko, L.G., Soliman, E.Z. (2015). The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population. Am Heart J, 170 (1):104–109.
Pewsner, D., J?ni, P., Egger, M. et al. (2007). Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ, 335, 711.
Bacharova, L., Schocken, D., Estes, E.H., Strauss, D. (2014). The role of ECG in the diagnosis of left ventricular hypertrophy. Curr Cardiol Rev, 10 (3), 257-261.
Krittayaphong, R.I., Nomsawadi, V., Muenkaew, M., Miniphan, M., Yindeengam, A., Udompunturak, S. (2013). Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging. J Med Assoc Thai, 2, 124–132.
Rider, O.J., Ntusi, N., Bull ,S.C. et al. (2016). Improvements in ECG accuracy for diagnosis of left ventricular hypertrophy in obesity Heart, 102, 1566–1572.
Rybakova, M.K., Alekhin, M.N., Mit'kov, V.V. (2008) Prakticheskoye rukovodstvo po ul'trazvukovoy diagnostike. Ekhokardiografiya. ispr. i dop.[A practical guide to ultrasound diagnostics. Echocardiography. corrected and add.]. Moskva:Vidar-M.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.